• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺单纯导管原位癌与伴浸润性疾病的导管原位癌之间的基因组差异:一项校准后的比较基因组杂交研究

Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.

作者信息

Iakovlev Vladimir V, Arneson Nona C R, Wong Vietty, Wang Chunjie, Leung Stephanie, Iakovleva Gaiane, Warren Keisha, Pintilie Melania, Done Susan J

机构信息

Division of Applied Medical Oncology, Toronto, Ontario, Canada.

出版信息

Clin Cancer Res. 2008 Jul 15;14(14):4446-54. doi: 10.1158/1078-0432.CCR-07-4960.

DOI:10.1158/1078-0432.CCR-07-4960
PMID:18628458
Abstract

PURPOSE

In the quest for new targets, genomes of ductal carcinoma in situ (DCIS) and infiltrating duct carcinoma (IDC) have been compared previously; however, genomic alterations associated with cancer progression were difficult to identify. We hypothesized that significant events can be detected by comparing lesions with a broader range of behavior: from pure DCIS to IDC associated with lymph node metastasis.

EXPERIMENTAL DESIGN

Array comparative genomic hybridization, calibrated by self-self hybridization tests, was used to study 6 cases of pure DCIS and 17 cases of DCIS paired with IDC where 8 tumors had spread to the local lymph nodes.

RESULTS

Pure DCIS exhibited a marginally higher degree of genomic complexity than DCIS and IDC components of invasive tumors. The latter two showed similarity between tumors and between components of the same tumor with several regions detected preferentially compared with pure DCIS. IDC associated with lymph node metastases showed similarity of genomic profiles as a group. Gain on 17q22-24.2 was associated with higher histologic grade, large IDC size, lymphatic/vascular invasion, and lymph node metastasis (P < 0.05).

CONCLUSIONS

Our findings suggest that DCIS and IDC are associated with specific genomic events. DCIS associated with IDC is genomically similar to the invasive component and therefore may represent either a clone with high invasive potential or invasive cancer spreading through the ducts. Specifically, gain on 17q22-24.2 is a candidate region for further testing as a predictor of invasion when detected in DCIS and predictor of nodal metastasis when detected in DCIS or IDC.

摘要

目的

在寻找新靶点的过程中,先前已对导管原位癌(DCIS)和浸润性导管癌(IDC)的基因组进行了比较;然而,与癌症进展相关的基因组改变难以识别。我们假设,通过比较具有更广泛行为范围的病变(从纯DCIS到伴有淋巴结转移的IDC),可以检测到重大事件。

实验设计

通过自我杂交测试校准的阵列比较基因组杂交技术,用于研究6例纯DCIS和17例与IDC配对的DCIS病例,其中8例肿瘤已扩散至局部淋巴结。

结果

纯DCIS的基因组复杂性略高于浸润性肿瘤的DCIS和IDC成分。后两者在肿瘤之间以及同一肿瘤的成分之间表现出相似性,与纯DCIS相比,有几个区域被优先检测到。伴有淋巴结转移的IDC作为一个组显示出基因组图谱的相似性。17q22 - 24.2区域的扩增与更高的组织学分级、较大的IDC大小、淋巴管/血管侵犯以及淋巴结转移相关(P < 0.05)。

结论

我们的研究结果表明,DCIS和IDC与特定的基因组事件相关。与IDC相关的DCIS在基因组上与浸润成分相似,因此可能代表具有高侵袭潜能的克隆或通过导管扩散的浸润性癌。具体而言,17q22 - 24.2区域的扩增是一个候选区域,当在DCIS中检测到时,可作为侵袭的预测指标进一步测试;当在DCIS或IDC中检测到时,可作为淋巴结转移的预测指标。

相似文献

1
Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.乳腺单纯导管原位癌与伴浸润性疾病的导管原位癌之间的基因组差异:一项校准后的比较基因组杂交研究
Clin Cancer Res. 2008 Jul 15;14(14):4446-54. doi: 10.1158/1078-0432.CCR-07-4960.
2
Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.原发性乳腺癌与其前哨淋巴结及更远处淋巴结转移灶的基因组改变:一项比较基因组杂交研究
Genes Chromosomes Cancer. 2009 Dec;48(12):1091-101. doi: 10.1002/gcc.20711.
3
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.有证据表明,在乳腺导管癌进展过程中,细胞的分子变化先于形态学改变出现。
Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.
4
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.通过荧光原位杂交和免疫组织化学检测纯导管原位癌以及浸润性导管癌的导管内和浸润成分中的HER2状态。
Histopathology. 2006 May;48(6):702-7. doi: 10.1111/j.1365-2559.2006.02403.x.
5
Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.通过比较基因组杂交检测导管内乳腺癌的基因变化。
Am J Pathol. 1997 Apr;150(4):1465-71.
6
Patterns of chromosomal alterations in breast ductal carcinoma in situ.乳腺导管原位癌的染色体改变模式
Clin Cancer Res. 2004 Aug 1;10(15):5160-7. doi: 10.1158/1078-0432.CCR-04-0165.
7
Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.纯性普通导管增生作为乳腺癌前体时染色体改变的证据。
Oncol Rep. 2008 Jun;19(6):1469-75.
8
Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.乳腺单纯导管原位癌及导管浸润癌的原位成分。一项初步形态计量学研究。
J Exp Clin Cancer Res. 2003 Jun;22(2):279-88.
9
Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.乳腺导管癌中雌激素受体、孕激素受体及c-erbB2癌基因蛋白表达的改变
Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.
10
Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.通过对匹配的原位导管癌和浸润性乳腺肿瘤进行表达谱分析,结合激光捕获显微切割和寡核苷酸微阵列分析鉴定出的进展特异性基因。
Cancer Res. 2006 May 15;66(10):5278-86. doi: 10.1158/0008-5472.CAN-05-4610.

引用本文的文献

1
Influence of Cancerization of Lobules in Ductal Carcinoma In Situ of the Breast on the Pathological Outcomes in Mastectomy Specimens.乳腺导管原位癌中小叶癌变对乳房切除术标本病理结果的影响。
Cancers (Basel). 2025 May 12;17(10):1634. doi: 10.3390/cancers17101634.
2
Tumor microenvironmental determinants of high-risk DCIS progression.高危导管原位癌进展的肿瘤微环境决定因素。
Res Sq. 2024 May 9:rs.3.rs-4126092. doi: 10.21203/rs.3.rs-4126092/v1.
3
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.
从导管原位癌到浸润性乳腺癌的进展:分子特征及临床意义。
Signal Transduct Target Ther. 2024 Apr 3;9(1):83. doi: 10.1038/s41392-024-01779-3.
4
Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective.同时性导管原位癌是否会影响浸润性导管癌乳腺癌患者的临床结局:亚洲视角。
Cancer Rep (Hoboken). 2022 Sep;5(9):e1646. doi: 10.1002/cnr2.1646. Epub 2022 Jul 26.
5
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target.LGR5 在乳腺癌及导管原位癌中的作用:一种诊断及预后生物标志物,也是治疗靶点。
BMC Cancer. 2020 Jun 10;20(1):542. doi: 10.1186/s12885-020-06986-z.
6
Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.多形性和华丽型小叶原位癌变异体的遗传分析:ERBB2/ERBB3 改变频繁,与经典小叶原位癌和浸润性小叶癌存在克隆关系。
Mod Pathol. 2020 Jun;33(6):1078-1091. doi: 10.1038/s41379-019-0449-8. Epub 2020 Jan 6.
7
The prognostic significance of co-existence ductal carcinoma in invasive ductal breast cancer: a large population-based study and a matched case-control analysis.浸润性导管癌中并存导管原位癌的预后意义:一项基于大人群的研究及配对病例对照分析
Ann Transl Med. 2019 Sep;7(18):484. doi: 10.21037/atm.2019.08.16.
8
DCIS with Microinvasion: Is It In Situ or Invasive Disease?微浸润性导管原位癌:是原位癌还是浸润性癌?
Ann Surg Oncol. 2019 Oct;26(10):3124-3132. doi: 10.1245/s10434-019-07556-9. Epub 2019 Jul 24.
9
A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.乳腺导管原位癌主动监测试验的回顾性替代方法。
Int J Cancer. 2020 Mar 1;146(5):1189-1197. doi: 10.1002/ijc.32362. Epub 2019 May 8.
10
Parity Differently Affects the Breast Cancer Specific Survival from Ductal Carcinoma In Situ to Invasive Cancer: A Registry-Based Retrospective Study from Korea.分娩次数对导管原位癌至浸润性癌的乳腺癌特异性生存影响各异:一项基于韩国登记处的回顾性研究
Breast Cancer (Auckl). 2019 Jan 27;13:1178223418825134. doi: 10.1177/1178223418825134. eCollection 2019.